Position in ALEC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,880,000
+$1,654,000 QoQ
Shares Held
3,200,000
-4.5% QoQ
Ownership
2.88%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALEC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026683 Capital Management, LLC holds $316,393,102 across 63 Biotechnology names. ALEC ranks #14 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
355,000 | $37,417,000 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
4,900,000 | $35,525,000 | |
| 3 | ANAB |
Anaptysbio, Inc
|
625,000 | $34,662,468 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
2,450,000 | $21,217,000 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,553,500 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
590,000 | $19,599,800 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
750,000 | $16,320,000 | |
| 8 | FOLD |
AMICUS THERAPEUTICS, INC.
|
775,000 | $11,206,500 |
All Filings in ALEC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,880,000 | 3,200,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,226,000 | 3,350,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,960,000 | 1,000,000 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||